Endoscopic Treatment Options in Lung Cancer
Airway Diseases: Volume 1-3, Springer International Publishing Ag, ss.1247-1283, 2023
- Yayın Türü: Kitapta Bölüm / Araştırma Kitabı
- Basım Tarihi: 2023
- Doi Numarası: 10.1007/978-3-031-22483-6_70-1
- Yayınevi: Springer International Publishing Ag
- Sayfa Sayıları: ss.1247-1283
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Significant changes have occurred in the epidemiology and prevention of lung cancer in the past decade due to changes in smoking patterns, lung cancer genetics, the role of the immune system in lung cancer control, and breakthrough developments in lung cancer treatment options [1]. However, it still continues to be the most common cancer type that causes death [2]. In 2018, 2.09 million new cases (11.6% of total cancer cases) and 1.76 million deaths (18.4% of total cancer deaths) were identified globally in lung cancer patients, with a higher rate of new cases and deaths compared to 2012 [3–5]. Due to the global increase in the number of smokers in recent years, the lung cancer burden is expected to continue to increase in the coming years.